References
- M.C. Carreiras and J.L. Marco, Recent approaches to novel anti-Alzheimer therapy, Curr. Pharma. Des. 10 (2004), pp. 3167–3175. doi:https://doi.org/10.2174/1381612043383421.
- E. Giacobini, Cholinesterases: New roles in brain function and in Alzheimer’s disease, Neurochem. Res. 28 (2003), pp. 515–522. doi:https://doi.org/10.1023/A:1022869222652.
- U. Holzgrabe, P. Kapková, V. Alptüzün, J. Scheiber, and E. Kugelmann, Targeting acetylcholinesterase to treat neurodegeneration, Expert Opin. Ther. Targets 11 (2007), pp. 161–179. doi:https://doi.org/10.1517/14728222.11.2.161.
- J. Chaudière and R. Ferrari-Iliou, Intracellular antioxidants: From chemical to biochemical mechanisms, Food Chem. Toxicol. 37 (1999), pp. 949–962. doi:https://doi.org/10.1016/S0278-6915(99)00090-3.
- V.P. Whittaker, How the cholinesterases got their modern names, Chem. Biol. Interact. 187 (2010), pp. 23–26. doi:https://doi.org/10.1016/j.cbi.2010.02.041.
- S. Darvesh, D.A. Hopkins, and C. Geula, Neurobiology of butyrylcholinesterase, Nat. Rev. Neurosci. 4 (2003), pp. 131–138. doi:https://doi.org/10.1038/nrn1035.
- M.I. Rodríguez-Franco, M.I. Fernández-Bachiller, C. Pérez, A. Castro, and A. Martínez, Design and synthesis of N-benzylpiperidine–purine derivatives as new dual inhibitors of acetyl-and butyrylcholinesterase, Bioorg. Med. Chem. 13 (2005), pp. 6795–6802. doi:https://doi.org/10.1016/j.bmc.2005.07.019.
- F. Mangialasche, A. Solomon, B. Winblad, P. Mecocci, and M. Kivipelto, Alzheimer’s disease: Clinical trials and drug development, Lancet Neurol. 9 (2010), pp. 702–716. doi:https://doi.org/10.1016/S1474-4422(10)70119-8.
- M. Rosini, E. Simoni, M. Bartolini, A. Tarozzi, R. Matera, A. Milelli, P. Hrelia, V. Andrisona, M.L. Bolognesi, and C. Melchiorre, Exploiting the lipoic acid structure in the search for novel multitarget ligands against Alzheimer’s disease, Eur. J. Med. Chem. 46 (2011), pp. 5435–5442. doi:https://doi.org/10.1016/j.ejmech.2011.09.001.
- W.R. Markesbery, Oxidative stress hypothesis in Alzheimer’s disease, Free Radic. Biol. Med. 23 (1997), pp. 134–147. doi:https://doi.org/10.1016/S0891-5849(96)00629-6.
- A.H. Samir, R.M. Rumez, and H.A. Fadhil, Synthesis and characterization of some new oxazepine compounds containing 1,3,4-thiadiazole ring derived form d-erythroascorbic acid, Int. J. Appl. Chem. 13 (2017), pp. 393–407.
- A.K. Gadad, M.N. Noolvi, and R.V. Karpoormath, Synthesis and anti-tubercular activity of a series of 2-sulfonamido/trifluoromethyl-6-substituted imidazo [2,1-b]-1,3,4-thiadiazole derivatives, Bioorg. Med. Chem. 12 (2004), pp. 5651–5659. doi:https://doi.org/10.1016/j.bmc.2004.07.060.
- A. Hiremathad and L. Piemontese, Heterocyclic compounds as key structures for the interaction with old and new targets in Alzheimer’s disease therapy, Neural. Regen. Res. 12 (2007), pp. 1256–1261.
- A. Mumtaz, T. Mahmud, M.R. Elsegood, and G.W. Weaver, Synthesis and characterization of new Schiff base transition metal complexes derived from drug together with biological potential study, J. Nucl. Med. Radiat. Ther. 7 (2016), pp. 2. doi:https://doi.org/10.4172/2155-9619.1000310.
- N.P. Belskaya, W. Dehaen, and V.A. Bakulev, Synthesis and properties of hydrazones bearing amide, thioamide and amidine functions, Arkivoc 2010 (2010), pp. 275–332. doi:https://doi.org/10.3998/ark.5550190.0011.108.
- G.L. Ellman, K.D. Courtney, V. Andres, and R.M. Featherstone, A new and rapid colorimetric determination of acetylcholinesterase activity, Bio-chem. Pharmacol. 7 (1961), pp. 88–95. doi:https://doi.org/10.1016/0006-2952(61)90145-9.
- M.S. Blois, Antioxidant determinations by the use of a stable free radical, Nature 181 (1958), pp. 1199–1200. doi:https://doi.org/10.1038/1811199a0.
- B. Noshadi, T. Ercetin, C. Luise, M.Y. Yuksel, W. Sippl, M.F. Sahin, M. Gazi, and H.O. Gulcan, Synthesis, characterization, molecular docking, and biological activities of some natural and synthetic urolithin analogs, Chem. Biodiver. 17 (2020), pp. e2000197. doi:https://doi.org/10.1002/cbdv.202000197.
- Y. Liu, M. Grimm, W.T. Dai, M.C. Hou, Z.X. Xiao, and Y. Cao, CB-Dock: A web server for cavity detection-guided protein–ligand blind docking, Acta Pharmacol. Sin. 41 (2020), pp. 138–144. doi:https://doi.org/10.1038/s41401-019-0228-6.
- O. Trott and A.J. Olson, AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, J. Comput. Chem. 31 (2010), pp. 455–461. doi:https://doi.org/10.1002/jcc.21334.
- F. Nachon, E. Carletti, C. Ronco, M. Trovaslet, Y. Nicolet, L. Jean, and P.Y. Renard, Crystal structures of human cholinesterases in complex with huprine W and tacrine: Elements of specificity for anti-Alzheimer’s drugs targeting acetyl-and butyryl-cholinesterase, Biochem. J. 453 (2013), pp. 393–399. doi:https://doi.org/10.1042/BJ20130013.
- A. Waterhouse, M. Bertoni, S. Bienert, G. Studer, G. Tauriello, R. Gumienny, F.T. Heer, T. Beer, C. Rempfer, L. Bordoli, R. Lepore, and T. Schwede, Swiss-MODEL: Homology modelling of protein structures and complexes, Nucleic Acids Res. 46 (2018), pp. W296–W303. doi:https://doi.org/10.1093/nar/gky427.
- Y. Cao and L. Li, Improved protein–ligand binding affinity prediction by using a curvature-dependent surface-area model, Bioinformatics 30 (2014), pp. 1674–1680. doi:https://doi.org/10.1093/bioinformatics/btu104.
- E.W. Bell and Y. Zhang, DockRMSD: An open-source tool for atom mapping and RMSD calculation of symmetric molecules through graph isomorphism, J. Cheminf. 11 (2019), pp. 1–9. doi:https://doi.org/10.1186/s13321-019-0362-7.
- M.J. Abraham, T. Murtola, R. Schulz, S. Páll, J.C. Smith, B. Hess, and E. Lindahl, GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers, SoftwareX 1–2 (2015), pp. 19–25. doi:https://doi.org/10.1016/j.softx.2015.06.001.
- C. Oostenbrink, A. Villa, A.E. Mark, and W.F. Van Gunsteren, A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6, J. Comput. Chem. 25 (2004), pp. 1656–1676. doi:https://doi.org/10.1002/jcc.20090.
- A.W. Schüttelkopf and D.M.F. van Aalten, PRODRG: A tool for high-throughput crystallography of protein-ligand complexes, Acta Crystallogr. D Acta Crystal. D 60 (2004), pp. 1355–1363. doi:https://doi.org/10.1107/S0907444904011679.
- R. Kumari and R. Kumar, Open Source Drug Discovery Consortium, Lynn, A. g_mmpbs, A GROMACS tool for high-throughput MM-PBSA calculations, J. Chem. Inf. Model. 54 (2014), pp. 1951–1962. doi:https://doi.org/10.1021/ci500020m.
- S. Grimme, Semi empirical hybrid density functional with perturbative second order correlation, J. Chem. Phys 124 (2006), pp. 034108. doi:https://doi.org/10.1063/1.2148954.
- S. Grimme, J. Antony, S. Ehrlich, and H. Krieg, A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements, J. Chem. Phys. 132 (2010), pp. 154104. doi:https://doi.org/10.1063/1.3382344.
- E. Cancès, B. Mennucci, and J. Tomasi, A new integral equation formalism for the polarizable continuum model: Theoretical background and applications to isotropic and anisotropic dielectrics, J. Chem. Phys. 107 (1997), pp. 3032–3041. doi:https://doi.org/10.1063/1.474659.
- B. Mennucci and J. Tomasi, Continuum solvation models: A new approach to the problem of solute’s charge distribution and cavity boundaries, J. Chem. Phys. 106 (1997), pp. 5151–5158. doi:https://doi.org/10.1063/1.473558.
- B. Mennucci, E. Cancès, and J. Tomasi, Evaluation of solvent effects in isotropic and anisotropic dielectrics and in ionic solutions with a unified integral equation method: Theoretical bases, computational implementation, and numerical applications, J. Phys. Chem. B 101 (1997), pp. 10506–10517. doi:https://doi.org/10.1021/jp971959k.
- J. Tomasi, B. Mennucci, and E. Cancès, The IEF version of the PCM solvation method: An overview of a new method addressed to study molecular solutes at the QM ab initio level, J. Mol. Struct. Theochem. 464 (1999), pp. 211–226. doi:https://doi.org/10.1016/S0166-1280(98)00553-3.
- M. Erol, I. Celik, O. Temiz-Arpaci, H. Goker, F. Kaynak-Onurdag, and S. Okten, 1H-Benzimidazole-5-carboxamidine derivatives: Design, synthesis, molecular docking, DFT and antimicrobial studies, New J. Chem. 44 (2020), pp. 21309–21317. doi:https://doi.org/10.1039/D0NJ01899F.
- V. GaussView, D. Roy, A.K. Todd, and M.M. John, Semichem Inc, Shawnee Mission, KS, 2016.
- I. Celik, M. Erol, and G. Kuyucuklu, Molecular modeling, density functional theory, ADME prediction and antimicrobial activity studies of 2-(substituted)oxazolo[4,5- b]pyridine derivatives, New J. Chem. 45 (2021), pp. 11108–11118. doi:https://doi.org/10.1039/D1NJ00701G.
- I. Celik, M. Erol, and Z. Duzgun, In silico evaluation of potential inhibitory activity of remdesivir, favipiravir, ribavirin and galidesivir active forms on SARS-CoV-2 RNA polymerase, Mol. Divers. (2021), pp. 1–14.
- U.A. Çevik, I. Celik, A. Işık, R.R. Pillai, T.E. Tallei, R. Yadav, Y. Ozkay, and Z.A. Kaplancıklı, Synthesis, molecular modeling, quantum mechanical calculations and ADME estimation studies of benzimidazole-oxadiazole derivatives as potent antifungal agents, J. Mol. Struct. 1252 (2022), pp. 132095. doi:https://doi.org/10.1016/j.molstruc.2021.132095.
- O.V. Dolomanov, L.J. Bourhis, R.J. Gildea, J.A.K. Howard, and H. Puschmann, Olex2-1.2 program. A complete structure solution, refinement and analysis program, J. Appl. Crystallogr. 42 (2009), pp. 339–34. doi:https://doi.org/10.1107/S0021889808042726.